Table 2.

Effect of BSO and 4-OH-IF on MHC and costimulatory molecule expression on DCs


Surface marker

Control, % (MFI)

BSO, % (MFI)

4-OH-IF, % (MFI)
HLA-DR   99 ± 1 (349 ± 137)   100 (395 ± 206)   100 (342 ± 111)  
MHC class I   99 ± 1 (216 ± 104)   99 ± 1 (197 ± 88)   100 (181 ± 59)  
CD86   25 ± 13 (76 ± 19)   26 ± 18 (65 ± 16)   23 ± 14 (66 ± 22)  
CD40   98 ± 1 (66 ± 30)   97 ± 1 (52 ± 13)   79 ± 5 (31 ± 1)  
CD83
 
22 ± 11 (36 ± 4)
 
22 ± 14 (34 ± 3)
 
19 ± 10 (34 ± 2)
 

Surface marker

Control, % (MFI)

BSO, % (MFI)

4-OH-IF, % (MFI)
HLA-DR   99 ± 1 (349 ± 137)   100 (395 ± 206)   100 (342 ± 111)  
MHC class I   99 ± 1 (216 ± 104)   99 ± 1 (197 ± 88)   100 (181 ± 59)  
CD86   25 ± 13 (76 ± 19)   26 ± 18 (65 ± 16)   23 ± 14 (66 ± 22)  
CD40   98 ± 1 (66 ± 30)   97 ± 1 (52 ± 13)   79 ± 5 (31 ± 1)  
CD83
 
22 ± 11 (36 ± 4)
 
22 ± 14 (34 ± 3)
 
19 ± 10 (34 ± 2)
 

DCs were cultured for 24 hours in the presence of BSO (0.5 mM) on day 7 or with 4-OH-IF (100 μM) for 90 minutes on day 8. Cells were then washed and stained with antibodies to the above molecules. Surface marker expression was analyzed by FACS analysis. Results are expressed as the percentage positive cells and the mean fluorescence intensity (MFI) and represent the mean ± SD of 3 experiments from 3 donors.

Close Modal

or Create an Account

Close Modal
Close Modal